← FDA Drug Approvals (Drugs@FDA)
KADCYLA
BLA · Biologics License Application · Sponsor: GENENTECH · Approved 2013-02-22
Drug application
- FDA Application #
BLA125427- Application type
- Biologics License Application
- Brand name
- KADCYLA
- Generic name
- ADO-TRASTUZUMAB EMTANSINE
- Active ingredients
- ADO-TRASTUZUMAB EMTANSINE
- Dosage form
- VIAL
- Route
- SINGLE-USE
- Marketing status
- Prescription
- Sponsor
- GENENTECH
- Manufacturer
- Genentech, Inc.
- First approval
- 2013-02-22
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown